伟思医疗
(688580)
| 流通市值：51.71亿 | | | 总市值：51.71亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 325,530,311.85 | 210,453,384.34 | 95,912,701.63 | 400,058,923.31 |
| 营业收入 | 325,530,311.85 | 210,453,384.34 | 95,912,701.63 | 400,058,923.31 |
| 二、营业总成本 | 235,847,318 | 149,767,936.06 | 66,399,984.17 | 324,845,883.81 |
| 营业成本 | 107,877,419.58 | 71,365,174.28 | 31,984,614.54 | 138,226,444.43 |
| 税金及附加 | 4,849,462.71 | 2,973,485.55 | 1,411,588.66 | 5,531,255.12 |
| 销售费用 | 61,113,366.77 | 37,021,094.59 | 14,856,454.13 | 94,371,066.87 |
| 管理费用 | 32,645,201.87 | 19,829,588.28 | 9,530,691.39 | 44,548,847.18 |
| 研发费用 | 31,712,293.48 | 20,483,371.22 | 9,664,611.61 | 50,613,388.74 |
| 财务费用 | -2,350,426.41 | -1,904,777.86 | -1,047,976.16 | -8,445,118.53 |
| 其中:利息费用 | 1,050,393.12 | 701,883.15 | 351,255.24 | 1,308,733.32 |
| 其中:利息收入 | 3,426,329.16 | 2,615,347.78 | 1,402,873.76 | 9,772,871.34 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | - | 2,419,469.21 |
| 加:投资收益 | 9,763,745.78 | 6,593,169.16 | 3,126,773.51 | 11,336,994.51 |
| 资产处置收益 | -864.63 | -864.63 | -864.63 | 3,909.66 |
| 资产减值损失(新) | -122,968.26 | - | - | -29,234.54 |
| 信用减值损失(新) | -149,229.7 | -180,911.06 | -84,188.61 | -1,276,267.87 |
| 其他收益 | 13,437,510.02 | 9,295,818.99 | 4,487,673.76 | 23,835,345.51 |
| 四、营业利润 | 112,611,187.06 | 76,392,660.74 | 37,042,111.49 | 111,503,255.98 |
| 加:营业外收入 | 276,467.32 | 155,019.38 | 4,560.1 | 1,846,339.35 |
| 减:营业外支出 | 13,487.25 | 11,598.68 | - | 70,832.72 |
| 五、利润总额 | 112,874,167.13 | 76,536,081.44 | 37,046,671.59 | 113,278,762.61 |
| 减:所得税费用 | 10,725,879.9 | 7,211,838.93 | 3,826,596.54 | 11,309,532.07 |
| 六、净利润 | 102,148,287.23 | 69,324,242.51 | 33,220,075.05 | 101,969,230.54 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 102,148,287.23 | 69,324,242.51 | 33,220,075.05 | 101,969,230.54 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 102,148,287.23 | 69,324,242.51 | 33,220,075.05 | 101,969,230.54 |
| 扣除非经常损益后的净利润 | 93,600,044.21 | 63,571,292.43 | 30,538,332.03 | 83,115,416.15 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.07 | 0.72 | 0.35 | 1.07 |
| (二)稀释每股收益 | 1.07 | 0.72 | 0.35 | 1.07 |
| 九、综合收益总额 | 102,148,287.23 | 69,324,242.51 | 33,220,075.05 | 101,969,230.54 |
| 归属于母公司股东的综合收益总额 | 102,148,287.23 | 69,324,242.51 | 33,220,075.05 | 101,969,230.54 |
| 公告日期 | 2025-10-23 | 2025-08-28 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |